212 related articles for article (PubMed ID: 10404836)
21. Thyroid transcription factor-1 in orbital adipose tissues: potential role in orbital thyrotropin receptor expression.
Bhattacharyya KK; Coenen MJ; Bahn RS
Thyroid; 2005 May; 15(5):422-6. PubMed ID: 15929662
[TBL] [Abstract][Full Text] [Related]
22. Forkhead Transcription Factor FOXO1 Is Regulated by Both a Stimulatory Thyrotropin Receptor Antibody and Insulin-Like Growth Factor-1 in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.
Kumar S; Coenen M; Iyer S; Bahn RS
Thyroid; 2015 Oct; 25(10):1145-50. PubMed ID: 26213859
[TBL] [Abstract][Full Text] [Related]
23. Adipogenesis in thyroid eye disease.
Crisp M; Starkey KJ; Lane C; Ham J; Ludgate M
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3249-55. PubMed ID: 11006210
[TBL] [Abstract][Full Text] [Related]
24. A drug-like antagonist inhibits thyrotropin receptor-mediated stimulation of cAMP production in Graves' orbital fibroblasts.
Neumann S; Pope A; Geras-Raaka E; Raaka BM; Bahn RS; Gershengorn MC
Thyroid; 2012 Aug; 22(8):839-43. PubMed ID: 22784331
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis of ophthalmopathy in autoimmune thyroid disease.
Heufelder AE
Rev Endocr Metab Disord; 2000 Jan; 1(1-2):87-95. PubMed ID: 11704996
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of rat preadipocytes is accompanied by expression of thyrotropin receptors.
Haraguchi K; Shimura H; Lin L; Endo T; Onaya T
Endocrinology; 1996 Aug; 137(8):3200-5. PubMed ID: 8754740
[TBL] [Abstract][Full Text] [Related]
27. Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs.
Cozma I; Zhang L; Uddin J; Lane C; Rees A; Ludgate M
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1630-5. PubMed ID: 17848636
[TBL] [Abstract][Full Text] [Related]
28. TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy.
Bahn RS
J Endocrinol Invest; 2004 Mar; 27(3):216-20. PubMed ID: 15164996
[TBL] [Abstract][Full Text] [Related]
29. Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.
Khoo TK; Coenen MJ; Schiefer AR; Kumar S; Bahn RS
Thyroid; 2008 Dec; 18(12):1291-6. PubMed ID: 18976167
[TBL] [Abstract][Full Text] [Related]
30. Basic Fibroblast Growth Factor Induces Adipogenesis in Orbital Fibroblasts: Implications for the Pathogenesis of Graves' Orbitopathy.
Schrijver B; Kooiman MA; Kasteleijn E; van Holten-Neelen C; Virakul S; Paridaens D; Peeters RP; van Hagen PM; Dalm VASH; Dik WA
Thyroid; 2019 Mar; 29(3):395-404. PubMed ID: 30724135
[TBL] [Abstract][Full Text] [Related]
31. Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?
Wiersinga WM
J Clin Endocrinol Metab; 2011 Aug; 96(8):2386-94. PubMed ID: 21677036
[TBL] [Abstract][Full Text] [Related]
32. Thyroid-associated eye disease.
Heufelder AE; Joba W
Strabismus; 2000 Jun; 8(2):101-11. PubMed ID: 10980691
[TBL] [Abstract][Full Text] [Related]
33. A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy.
Turcu AF; Kumar S; Neumann S; Coenen M; Iyer S; Chiriboga P; Gershengorn MC; Bahn RS
J Clin Endocrinol Metab; 2013 May; 98(5):2153-9. PubMed ID: 23482611
[TBL] [Abstract][Full Text] [Related]
34. The Role of Sphingosine-1-Phosphate in Adipogenesis of Graves' Orbitopathy.
Kim SE; Lee JH; Chae MK; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):301-11. PubMed ID: 26830367
[TBL] [Abstract][Full Text] [Related]
35. Current Insights into the Pathogenesis of Graves' Ophthalmopathy.
Bahn RS
Horm Metab Res; 2015 Sep; 47(10):773-8. PubMed ID: 26361262
[TBL] [Abstract][Full Text] [Related]
36. Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts.
Bell A; Gagnon A; Grunder L; Parikh SJ; Smith TJ; Sorisky A
Am J Physiol Cell Physiol; 2000 Aug; 279(2):C335-40. PubMed ID: 10912999
[TBL] [Abstract][Full Text] [Related]
37. Expression of Endogenous Putative TSH Binding Protein in Orbit.
Draman MS; Grennan-Jones F; Taylor P; Muller I; Evans S; Haridas A; Morris DS; Rees DA; Lane C; Dayan C; Zhang L; Ludgate M
Curr Issues Mol Biol; 2021 Oct; 43(3):1794-1804. PubMed ID: 34889904
[TBL] [Abstract][Full Text] [Related]
38. Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease.
Smith TJ; Padovani-Claudio DA; Lu Y; Raychaudhuri N; Fernando R; Atkins S; Gillespie EF; Gianoukakis AG; Miller BS; Gauger PG; Doherty GM; Douglas RS
J Clin Endocrinol Metab; 2011 Dec; 96(12):3827-37. PubMed ID: 21956421
[TBL] [Abstract][Full Text] [Related]
39. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
40. Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves' ophthalmopathy.
Park M; Banga JP; Kim GJ; Kim M; Lew H
Stem Cell Res Ther; 2019 Aug; 10(1):246. PubMed ID: 31399042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
